Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06768996 · ClinicalTrials.gov registry record · NA

Music, Social Attention, and Dementia

A NA study of Alzheimer Disease and Frontotemporal Dementia, sponsored by University of California, San Francisco.

Active
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06768996: Active NA study of Alzheimer Disease and Frontotemporal Dementia, sponsored by University of California, San Francisco.

NCT06768996 is a NA study of Alzheimer Disease and Frontotemporal Dementia that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 80 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06768996, a NA study of Alzheimer Disease and Frontotemporal Dementia, is active but no longer recruiting, sponsored by University of California, San Francisco.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

This is an exploratory mixed-methods control-treatment study to evaluate if participation in rhythmic musical activities improves social attention and connectedness in individuals living with mild to moderate bvFTD and AD, and their caregivers. Secondary objectives include evaluating the potential relationships between brain networks associated with rhythm production, social attention, and connectedness in these populations.

Primary Outcome

Dependent Variable. Change in social attention will be measured by the TASIT, a 16-item instrument that measures social attention from the care recipient perspective. Items are sectioned by emotion recognition, social inference minimum (sarcasm) or enriched (lies) and assessed using standardized yes-no questions at the end of each section based on four types: think, feel, say, or do.

Interventions

  • BEHAVIORAL Synchronous Rhythm Production
  • BEHAVIORAL Solo Rhythm Production

Study Locations (1)

California

  • Sandler Neurosciences Center - San Francisco

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-01-10
Est. Completion 2026-12-01
Phase NA

What the registry record for NCT06768996 still lists

NCT06768996 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Synchronous Rhythm Production is the first listed.

NCT06768996 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06768996 about?

NCT06768996 is a clinical study titled "Music, Social Attention, and Dementia". This is an exploratory mixed-methods control-treatment study to evaluate if participation in rhythmic musical activities improves social attention and connectedness in individuals living with mild to moderate bvFTD and AD, and their caregivers. Secondary objectives include evaluating the potential r...

What is the current status of trial NCT06768996?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-01-10. Estimated completion is 2026-12-01.

What conditions does trial NCT06768996 study?

This clinical trial studies the following conditions: Alzheimer Disease, Frontotemporal Dementia.

What interventions are being tested in trial NCT06768996?

The interventions under investigation include: Synchronous Rhythm Production (BEHAVIORAL), Solo Rhythm Production (BEHAVIORAL).

Who is sponsoring clinical trial NCT06768996?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06768996 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06768996's enrollment target sits among peer trials

80 168th of 306 higher than 134 of 306 other Alzheimer Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06768996, the US trial registry maintained by the National Library of Medicine. NCT06768996 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.